Article Text

Download PDFPDF
Role of autologous serum in persistent epithelial defects
  1. N Mukerji,
  2. R Sinha,
  3. R B Vajpayee
  1. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India
  1. Correspondence to: Rasik B Vajpayee, RP Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi - 110029, India; rasikvajpayee{at}rediffmail.com

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Poon et al1 in their excellent article have reiterated the efficacy of autologous serum in the treatment of persistent epithelial defects (PEDs) of the cornea. We would like to invite the attention of the authors to certain aspects of the study.

The authors have considered a period of 1 week for labelling an epithelial defect to be persistent. However, most studies on a similar subject have taken …

View Full Text